Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy
Goldman, Jonathan W.; Shi, Peipei; Reck, Martin; Paz-Ares, Luis; Koustenis, Andrew; Hurt, Karla C.
- 期刊名称Clinical Lung Cancer
- 作者Goldman, Jonathan W.; Shi, Peipei; Reck, Martin; Paz-Ares, Luis; Koustenis, Andrew; Hurt, Karla C.
- 印刷ISSN1525-7304
- 文件大小287.35KB
- 发表时间2015-8
- DOI10.1016/j.cllc.2015.08.003